The goal in selecting these recent articles was to help identify literature that may change the clinical practice of women’s health for practitioners in the primary care setting. Articles were identified by reviewing the high-impact medical and women’s health journals, national guidelines, ACP JournalWise, and NEJM Journal Watch. In this Clinical Update, we selected recent publications relevant to the cardiovascular health of women.
TokgozogluL, LibbyP. The dawn of a new era of targeted lipid-lowering therapies. Eur Heart J, 2022; 43:3198; doi: 10.1093/eurheartj/ehab841
2.
NidorfSM, FioletATL, MosterdA, et al.; LoDoCo2 Trial Investigators. Colchicine in patients with chronic coronary disease. N Engl J Med, 2020; 383(19):1838–1847; doi: 10.1056/NEJMoa2021372
3.
RidkerPM, EverettBM, ThurenT, et al.; CANTOS Trial Group. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med, 2017; 377(12):1119–1131; doi: 10.1056/NEJMoa1707914
4.
NissenSE, WolskiK, BalogC, et al.Single ascending dose study of a short interfering RNA targeting lipoprotein (a) production in individuals with elevated plasma lipoprotein (a) levels. JAMA, 2022; 327(17):1679–1687; doi: 10.1001/jama.2022.5050
5.
TsimikasS, Karwatowska-ProkopczukE, Gouni-BertholdI, et al.; AKCEA-APO(a)-LRx Study Investigators. Lipoprotein (a) reduction in persons with cardiovascular disease. N Engl J Med, 2020; 382(3):244–255; doi: 10.1056/NEJMoa1905239
6.
RexrodeKM, MadsenTE, YuAYX, et al.The impact of sex and gender on stroke. Circ Res, 2022; 130(4):512–528; doi: 10.1161/CIRCRESAHA.121.319915
7.
FeiginVL, NguyenG, CercyK, et al.; GBD 2016 Lifetime Risk of Stroke Collaborators. Global, regional, and country-specific lifetime risks of stroke, 1990 and 2016. N Engl J Med, 2018; 379(25):2429–2437; doi: 10.1056/NEJMoa1804492
8.
ChihHJ, EliasFTS, GaudetL, et al.Assisted reproductive technology and hypertensive disorders of pregnancy: Systematic review and meta-analyses. BMC Pregnancy Childbirth, 2021; 21(1):449; doi: 10.1186/s12884-021-03938-8
9.
DayanN, JosephKS, FellDB, et al.Infertility treatment and risk of severe maternal morbidity: A propensity score-matched cohort study. CMAJ, 2019; 191(5):E118–E127; doi: 10.1503/cmaj.181124
10.
SabrY, LisonkovaS, SkollA, et al.Severe maternal morbidity and maternal mortality associated with assisted reproductive technology. J Obstet Gynaecol Can, 2022; 44(9):978–986; doi: 10.1016/j.jogc.2022.05.012
11.
ShandleyLM, DeSantisCE, LeeJC, et al.Trends and outcomes of assisted reproductive technology cycles using a gestational carrier between 2014 and 2020. JAMA, 2023; 330(17):1691–1694; doi: 10.1001/jama.2023.11023
12.
MageeLA, BrownMA, HallDR, et al.The 2021 international society for the study of hypertension in pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens, 2022; 27:148–169; doi: 10.1016/j.preghy.2021.09.008
13.
CruzMO, GaoW, HibbardJU. What is the optimal time for delivery in women with gestational hypertension? Am J Obstet Gynecol, 2012; 207(3):214.e1–214.e6; doi: 10.1016/j.ajog.2012.06.009
14.
RamM, BergerH, GearyM, et al.; Diabetes, Obesity and Hypertension in Pregnancy Research Network (DOH-NET) and the Southern Ontario Obstetrical Network (SOON) Investigators. Timing of delivery in women with chronic hypertension. Obstet Gynecol, 2018; 132(3):669–677; doi: 10.1097/AOG.0000000000002800
15.
VijgenSM, KoopmansCM, OpmeerBC, et al.; HYPITAT study group. An economic analysis of induction of labour and expectant monitoring in women with gestational hypertension or pre-eclampsia at term (HYPITAT trial). BJOG, 2010; 117(13):1577–1585; doi: 10.1111/j.1471-0528.2010.02710.x
16.
MahoneyAD, JainL. Respiratory disorders in moderately preterm, late preterm, and early term infants. Clin Perinatol, 2013; 40(4):665–678; doi: 10.1016/j.clp.2013.07.004
17.
RothGA, MensahGA, JohnsonCO, et al.; GBD-NHLBI-JACC Global Burden of Cardiovascular Diseases Writing Group. Global burden of cardiovascular diseases and risk factors, 1990-2019: Update from the GBD 2019 study. J Am Coll Cardiol, 2020; 76(25):2982–3021; doi: 10.1016/j.jacc.2020.11.010
18.
GarciaM, MulvaghSL, MerzCN, et al.Cardiovascular disease in women: Clinical perspectives. Circ Res, 2016; 118(8):1273–1293; doi: 10.1161/CIRCRESAHA.116.307547
19.
GeraghtyL, FigtreeGA, SchutteAE, et al.Cardiovascular disease in women: From pathophysiology to novel and emerging risk factors. Heart Lung Circ, 2021; 30(1):9–17; doi: 10.1016/j.hlc.2020.05.108
20.
GoodingHC, BrownCA, LiuJ, et al.Will teens go red? Low cardiovascular disease awareness among young women. J Am Heart Assoc, 2019; 8(6):e011195; doi: 10.1161/JAHA.118.011195
21.
HayesSN, WoodSF, MieresJH, et al.; Scientific Advisory Council of WomenHeart: The National Coalition for Women With Heart Disease. Taking a giant step toward women’s heart health: Finding policy solutions to unanswered research questions. Womens Health Issues, 2015; 25(5):429–432; doi: 10.1016/j.whi.2015.07.001
